Skip to main content
HighlightsHighlights Archive

Media Monitoring: 2 – 8 May

By May 7, 2024No Comments

New blood test shows promise in early detection of ovarian cancer

  • Epithelial ovarian cancer (EOC) accounts for the most significant number of deaths from female reproductive system cancers.
  • A new paper published in the British Journal of Cancer explores the potential utility of glycoproteins as biomarkers of EOC.
  • In the future, these types of models might allow the diagnosis of EOC to be made from a blood test.


MHRA’s AI regulatory strategy ensures patient safety and industry innovation into 2030


DSIT bolsters its leadership team to drive UK’s science and tech superpower mission

  • DSIT announces further appointments to its leadership team including Professor Christopher Johnson as Chief Scientific Advisor and new expert non-executives Dominic Field and Liz Cohen to the Departmental Board
  • The department also confirms the re-appointment of Shonnel Malani as Lead Non-Executive Director alongside other non-executives from DSIT’s start-up board – Melissa Di Donato, Jason Chin, Saul Klein


Immune cell discovery ‘could lead to personalised treatment for breast cancer’

  • Scientists have found that some immune cells hunt down cancer in the body, a discovery that could lead to personalised treatments for advanced breast cancer.
  • The study identified features of cells called immune B cells which make them successful at targeting tumours, including when cancer has spread to a different part of the body.
  • Researchers have developed a tool to identify these anti-cancer cells which could lead to improved, personalised immunotherapies


Prisoners with cancer in England more likely to die of it than other patients

  • Prisoners diagnosed with cancer are more likely than people in the general population to die of the disease, according to research.
  • The study, published as three linked papers by the Lancet Oncology and eClinicalMedicine, found that only 27% of cancer patients in jail were diagnosed following an urgent two-week referral, compared with 37% among the general population cohort.
  • They were also three times less likely to be diagnosed via screening.


International Development Innovation Alliance and WHO renew collaboration on scale-up of health innovations

  • The World Health Organization (WHO) and the International Development Innovation Alliance (IDIA) have agreed to renew their strategic Collaborative Agreement to support the scaling of health innovations to the end of 2025 to jointly accelerate health impact.
  • The collaboration was established in the beginning of 2021 to create a shared agenda and enable close collaboration and complementarity between the two entities to promote and facilitate the demand, supply, assessment and scale-up of proven health innovations for the benefit of low- and middle-income countries.


NHS in England needs 3 more years to recover from Covid, says chair (paywall)

Ben Kemp